Your browser doesn't support javascript.
loading
A single-center clinical study of 22 patients with acquired hemophilia / 中华血液学杂志
Chinese Journal of Hematology ; (12): 107-111, 2015.
Article in Chinese | WPRIM | ID: wpr-278899
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the feature of underlying disorders, clinical symptoms, diagnosis and treatment strategies of patients with acquired hemophilia(AH).</p><p><b>METHODS</b>The clinical data and laboratory tests results of 22 patients with AH from March 2010 to June 2014 were retrospectively analyzed.</p><p><b>RESULTS</b>A total of 22 patients with AH were enrolled in our study, including 20 patients diagnosed as acquired hemophilia A (AHA) and 2 as acquired hemophilia B (AHB). Among the AHA patients, there were 10 males and 10 females with the median age of 37.5 (range, 2-95) years old. The median activity of FVIII (FVIIIC) of the 20 AHA patients was 1.9% (0.5%-39.0%). Soft tissue hematoma (80.0%) and subcutaneous bleeding (75.0%) were the most common clinical symptoms. Two male children were diagnosed as AHB (age 1 and 3 years old, respectively) with mild bleeding symptoms, and the activities of FIX (FIXC) were 5.0% and 16.0%, respectively. In addition, an underlying disorder was found in 7 patients (31.8%). In laboratory testing, all patients had prolonged APTT, normal PT, decreased FVIIIC or FIXC, positive antibody screening test or antibody titer (2-32 BU), and negative for lupus anticoagulant and anticardiolipin antibody. Nineteen out of 20 patients were treated with blood products to stop acute bleeding episodes. Corticosteroid alone was applied to 7 patients, corticosteroid combined with other immunosuppressive agents to 11 patients, rituximab to 3 patients. Nineteen patients responded well to hemostatic treatment, except 1 patient who died of fatal bleeding. The FVIIIC of 8 patients increased to a normal level with the median time of 42.5(21-145) days. After treatment, the activity of FIXC of the 2 AHB patients achieved 35% and 24% in 48 and 60 days, respectively.</p><p><b>CONCLUSION</b>Acquired hemophilia is not an uncommon disease in clinical practices, which can occur in people of all ages. AH is a bleeding disorder with heterogeneous characteristics. Compared with adult, the clinical symptoms of children patients were mild, which lead to underdiagnosis.</p>
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Hemostatics / Retrospective Studies / Antibodies, Monoclonal, Murine-Derived / Rituximab / Hematoma / Hemophilia A / Hemorrhage / Immunosuppressive Agents Type of study: Observational study Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male Language: Chinese Journal: Chinese Journal of Hematology Year: 2015 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Hemostatics / Retrospective Studies / Antibodies, Monoclonal, Murine-Derived / Rituximab / Hematoma / Hemophilia A / Hemorrhage / Immunosuppressive Agents Type of study: Observational study Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male Language: Chinese Journal: Chinese Journal of Hematology Year: 2015 Type: Article